Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 9.66
+0.04 (0.42%)
Jun 11, 2026, 2:14 PM CST
SHA:603998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,224 | 4,935 | 4,576 | 4,819 | 3,521 | 2,920 | |
Market Cap Growth | 0.10% | 7.86% | -5.06% | 36.87% | 20.58% | 13.52% |
Enterprise Value | 4,476 | 5,328 | 5,188 | 5,463 | 3,898 | 3,469 |
Last Close Price | 9.62 | 10.93 | 9.75 | 10.03 | 7.12 | 5.81 |
PE Ratio | 13.74 | 16.11 | 17.93 | 25.80 | 12.32 | 41.69 |
Forward PE | 11.59 | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 |
PS Ratio | 2.36 | 2.83 | 2.57 | 2.96 | 1.97 | 1.86 |
PB Ratio | 2.30 | 2.74 | 2.64 | 3.03 | 2.34 | 2.24 |
P/TBV Ratio | 3.48 | 4.13 | 4.27 | 5.26 | 4.05 | 5.15 |
P/FCF Ratio | 12.58 | 17.49 | 45.69 | - | 27.01 | 3188.95 |
P/OCF Ratio | 9.54 | 12.83 | 23.47 | 55.06 | 11.67 | 15.73 |
EV/Sales Ratio | 2.50 | 3.05 | 2.92 | 3.35 | 2.17 | 2.21 |
EV/EBITDA Ratio | 11.12 | 14.00 | 16.17 | 23.24 | 17.43 | 18.18 |
EV/EBIT Ratio | 13.91 | 17.49 | 20.99 | 33.45 | 25.31 | 28.12 |
EV/FCF Ratio | 13.33 | 18.89 | 51.80 | - | 29.90 | 3788.09 |
Debt / Equity Ratio | 0.22 | 0.24 | 0.40 | 0.43 | 0.39 | 0.42 |
Debt / EBITDA Ratio | 1.01 | 1.12 | 2.17 | 2.87 | 2.56 | 2.74 |
Debt / FCF Ratio | 1.21 | 1.53 | 6.99 | - | 4.56 | 602.87 |
Net Debt / Equity Ratio | 0.08 | 0.09 | 0.23 | 0.28 | 0.10 | 0.21 |
Net Debt / EBITDA Ratio | 0.38 | 0.41 | 1.22 | 1.93 | 0.69 | 1.46 |
Net Debt / FCF Ratio | 0.45 | 0.55 | 3.91 | -3.45 | 1.18 | 303.32 |
Asset Turnover | 0.58 | 0.55 | 0.56 | 0.54 | 0.64 | 0.63 |
Inventory Turnover | 1.32 | 1.39 | 1.47 | 1.65 | 2.10 | 2.43 |
Quick Ratio | 0.50 | 0.50 | 0.49 | 0.38 | 0.80 | 0.45 |
Current Ratio | 0.91 | 0.88 | 0.88 | 0.74 | 1.19 | 0.69 |
Return on Equity (ROE) | 16.79% | 17.11% | 15.04% | 11.60% | 19.68% | 5.44% |
Return on Assets (ROA) | 6.48% | 6.02% | 4.87% | 3.40% | 3.42% | 3.12% |
Return on Invested Capital (ROIC) | 13.77% | 12.78% | 10.36% | 7.79% | 8.04% | 6.40% |
Return on Capital Employed (ROCE) | 16.60% | 16.00% | 12.60% | 8.90% | 8.00% | 8.50% |
Earnings Yield | 7.26% | 6.21% | 5.58% | 3.88% | 8.12% | 2.40% |
FCF Yield | 7.95% | 5.72% | 2.19% | -2.72% | 3.70% | 0.03% |
Dividend Yield | 4.70% | 2.74% | 2.56% | 2.89% | 4.92% | 2.58% |
Payout Ratio | 75.39% | 63.08% | 50.74% | 93.36% | 43.27% | 66.85% |
Buyback Yield / Dilution | 0.64% | 0.53% | 1.08% | -2.70% | 1.06% | -2.93% |
Total Shareholder Return | 5.34% | 3.28% | 3.64% | 0.19% | 5.98% | -0.35% |